Among the other recommendations on the WHO, there was the proposed addition of the footnote to the Schedule I section from the Conference, stating that preparations made up of predominantly cannabidiol instead of over 0.2 per cent of delta-nine-tetrahydrocannabinol aren't underneath Intercontinental Management.[35] Nevertheless, the proposal was in